Valuation: Novartis AG

Market Cap 301B 257B 241B 221B 414B 28,761B 419B 2,847B 1,110B 14,448B 1,129B 1,104B 47,789B P/E 2026 *
22.5x
P/E 2027 * 19.2x
Enterprise Value 333B 285B 267B 245B 459B 31,888B 465B 3,156B 1,231B 16,019B 1,251B 1,224B 52,984B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 5.36x
Free-Float
91.66%
Yield 2026 *
2.76%
Yield 2027 * 2.88%
1 day+0.95%
1 week+4.07%
Current month+0.65%
1 month+1.50%
3 months+6.86%
6 months-0.44%
Current year+16.26%
1 week 122
Extreme 122
128.26
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+4.07%+23.88%+41.58% 301B
+0.90%+6.80%+77.57%+129.14% 1,109B
+1.44%+4.32%+51.79%+62.29% 644B
+1.52%+6.65%+27.00%+77.18% 463B
+1.02%+5.77%+43.09%+47.70% 371B
+1.26%+6.81%+1.59%+14.67% 256B
+1.62%+5.58%+48.22%+68.15% 234B
+1.59%+2.09%-15.52%-52.29% 205B
+2.09%+6.02%+26.30%+93.17% 178B
+0.59%+4.44%+8.71%-24.40% 158B
Average +1.24%+3.44%+29.26%+45.72% 391.95B
Weighted average by Cap. +1.15%+3.42%+43.29%+69.15%

Financials

2026 *2027 *
Net sales 57.65B 49.38B 46.21B 42.3B 79.38B 5,516B 80.43B 546B 213B 2,771B 216B 212B 9,165B 61.31B 52.52B 49.14B 44.98B 84.42B 5,866B 85.53B 581B 226B 2,947B 230B 225B 9,747B
Net income 13.95B 11.95B 11.18B 10.24B 19.21B 1,335B 19.46B 132B 51.52B 671B 52.38B 51.24B 2,218B 15.5B 13.28B 12.42B 11.37B 21.34B 1,483B 21.63B 147B 57.25B 745B 58.21B 56.94B 2,464B
Net Debt 32.68B 27.99B 26.19B 23.98B 45B 3,127B 45.59B 309B 121B 1,571B 123B 120B 5,195B 27.82B 23.83B 22.3B 20.41B 38.3B 2,662B 38.81B 263B 103B 1,337B 104B 102B 4,422B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
21/08/26 CHF 127.42 +0.85% 2,706,020
20/08/26 CHF 126.34 -0.61% 1,856,746
19/08/26 CHF 127.12 +1.24% 2,053,740
18/08/26 CHF 125.56 +1.75% 1,794,769
17/08/26 CHF 123.40 +0.78% 1,293,936
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.15USD
Average target price
154.23USD
Spread / Average Target
-2.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock